IQVIA™ has announced that Novo Nordisk, has selected IQVIA’s market-leading Orchestrated Customer Engagement platform for deployment across Novo Nordisk International Operations.
Forrester To Acquire B2B Sales Research Firm, SiriusDecisions
IQVIA Technologies’ OCE for next-generation customer engagement seamlessly connects marketing, sales, medical science liaisons, account management, and other functions to enhance the customer experience, strengthen relationships and drive performance. IQVIA customers also benefit from more accurate decision-making through predictive analytics, machine learning and optimized performance. OCE is built on best-in-class platforms, including Salesforce.com, MuleSoft, Amazon Web Services, Heroku and Box.
Cloudinary to Showcase New Media Management Capabilities at AWS re:Invent 2018
Novo Nordisk plans to switch its existing platforms to OCE in 2019 and beyond for this global rollout, excluding Canada and the U.S., enabling them to streamline processes, further develop customer relationships and better anticipate, and respond to market changes.
Currently, IQVIA is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities.
